Identification of the inhibitory mechanism of FDA approved selective serotonin reuptake inhibitors: an insight from molecular dynamics simulation study.
about
The Human Kinome Targeted by FDA Approved Multi-Target Drugs and Combination Products: A Comparative Study from the Drug-Target Interaction Network PerspectiveExploring the Inhibitory Mechanism of Approved Selective Norepinephrine Reuptake Inhibitors and Reboxetine Enantiomers by Molecular Dynamics StudyPerformance Evaluation and Online Realization of Data-driven Normalization Methods Used in LC/MS based Untargeted Metabolomics Analysis.Revealing inhibition difference between PFI-2 enantiomers against SETD7 by molecular dynamics simulations, binding free energy calculations and unbinding pathway analysis.SVM-Prot 2016: A Web-Server for Machine Learning Prediction of Protein Functional Families from Sequence Irrespective of Similarity.Comparison of FDA Approved Kinase Targets to Clinical Trial Ones: Insights from Their System Profiles and Drug-Target Interaction Networks.Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics.Assessing the Performances of Protein Function Prediction Algorithms from the Perspectives of Identification Accuracy and False Discovery Rate.Revealing vilazodone's binding mechanism underlying its partial agonism to the 5-HT1A receptor in the treatment of major depressive disorder.Determining the Balance Between Drug Efficacy and Safety by the Network and Biological System Profile of Its Therapeutic Target
P2860
Q28553277-6DE168DA-9448-4DC0-8479-08DA628F61F5Q28833274-3FCBA9CE-020A-4131-9AD2-F570999E831AQ31148475-A3039885-D4CF-40DC-8A13-77ED4DF37364Q33572781-AAFEC408-CED3-4C9D-B6FC-E3F338315833Q36104137-EC98FC3E-005A-4306-8769-88125E9969DAQ42195551-4B7B170D-21CA-4A64-86ED-45D811641C7AQ47116549-50012520-9865-4804-823B-BC59F8CA057EQ47216858-BE1F7951-FFFB-4220-9FF7-D32FD507DED1Q47732078-BEBBE72C-D87F-451D-AAFB-4F38E445DD71Q59138094-9DFF63DC-60B3-404B-BBEB-6415173B68A9
P2860
Identification of the inhibitory mechanism of FDA approved selective serotonin reuptake inhibitors: an insight from molecular dynamics simulation study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Identification of the inhibito ...... lar dynamics simulation study.
@en
Identification of the inhibito ...... lar dynamics simulation study.
@nl
type
label
Identification of the inhibito ...... lar dynamics simulation study.
@en
Identification of the inhibito ...... lar dynamics simulation study.
@nl
prefLabel
Identification of the inhibito ...... lar dynamics simulation study.
@en
Identification of the inhibito ...... lar dynamics simulation study.
@nl
P2093
P2860
P50
P356
P1476
Identification of the inhibito ...... lar dynamics simulation study.
@en
P2093
P2860
P304
P356
10.1039/C5CP05771J
P407
P577
2016-01-08T00:00:00Z